Godavari Biorefineries Limited

This early-stage trial tested a new oral drug, MSP008-22, for safety and tolerability in 7 adults with advanced solid tumors (breast, ovarian, prostate, head and neck cancers). The main goal was to find the highest safe dose and identify side effects. This is a first step to see …

This early-stage study tested a new oral drug called MSP008-22 in 64 healthy adults to see if it is safe and how the body processes it. Participants received either the drug or a placebo, and researchers monitored for side effects. The goal was to check safety, not whether the dr…